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Video-assisted thoracoscopic surgery (VATS) has multiple indications for diagnosis and treatment of
many different thoracic diseases; the commonest are lung wedge resection, pleural and mediastinal
biopsy, treatment of pneumothorax, and pleurectomy. Moreover, in recent years a few surgeons have
performed routinely major lung anatomic resections by VATS approach, including segmentectomy,
lobectomy and pneumonectomy.
In our experience VATS constitutes about one-third of all thoracic surgical procedures. In the reviewed
literature as in the most frequent complications after VATS procedures are: prolonged air leak, bleeding,
infection, postoperative pain, port site recurrence and the need to convert the access in thoracotomy. The
complication and mortality rates are generally very low and VATS procedures are considered safe and
effective.
It is recommended that all thoracic surgery departments audit their VATS procedures for peri-operative
morbidity and mortality to compare results and outcomes.
 2008 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Video-assisted thoracoscopic surgery (VATS) procedures have
proved to be safe and effective for treatment of a large variety of
thoracic diseases, with low peri-operative complication rates as
reported in several large series of patients. Fifteen years after the
beginning of the widespread application of VATS, this paper
reviews the complications associated with VATS procedures.
2. Overall morbidity and mortality after VATS
In three large studies published in 1996 the overall complication
rates after a variety of VATS procedures were, respectively, 4%,1
4.3%2 and 3.7%,3 with no reported deaths attributable to the VATS
technique. Similarly, in the very large series reported by the Video
Assisted Thoracic Surgery Group (55 surgeons from 40 institutions
who performed general thoracic surgery as the majority of their
practices),4 the complications observed in 1358 patients under-
going VATS procedures were: air leak longer than 5 days in 3.2% ofsurgery.
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ciates Ltd. Published by Elsevier Ltpatients; atelectasis in 1.4%; arrhythmia in 1.3%; bleeding in 1.2%
(one-third required transfusion); pneumonia in 1.1%; prolonged
ventilator dependence in 1.0%; empyema in 0.6%; and wound
infection in 0.4%. Therewere no intraoperative deaths, and the total
postoperative mortality rate for the 1358 patients was 2.0% (27
patients). Causes of deaths were sepsis in seven patients, respira-
tory insufﬁciency in four, progression of malignancy in three,
pneumonia in two, renal failure in two; and hepatic failure, cardiac
arrest, pulmonary embolus, and stroke occurred each in one
patient.
In our Center for Thoracic Surgery at the University of Insubria in
Varese, after reviewing 1093 consecutive VATS procedures per-
formed from 1996 to July 2008 we recorded the following
complications: prolonged air leak in 4.7% of patients; pneumonia in
2%; bleeding (with blood transfusion) in 2%; andwound infection in
0.6%. Conversion to thoracotomy was necessary to complete the
procedure in 1.7% of cases; the peri-operative mortality was 0.6%
(seven patients died in the postoperative period due to: respiratory
failure (four patients), pneumonia (one patient), acute cardiac
disease (one patient), sepsis (one patient)).
Table 1 summarizes the main complications observed in seven
large series of VATS procedures and shows that the most prevalent
are prolonged air leak and bleeding, while other complications are
infrequent.1–7 We will analyse separately the prevalence and
feature of these complications of VATS procedures.d. All rights reserved.
Table 1
Postoperative complications after VATS procedures (case-mix and procedures differ) in International series.
References No. of patients Prolonged air leak Bleeding Wound infection Death
(%) (%) (%) (%)
Krasna et al.1 348 3 (0.9) 3 (0.9) n.d. nil
Yim and Liu2 1337 21 (1.6) 6 (0.4) 13 (0.9) 1 (0.1)
Jancovici et al.3 937 63 (6.7) 18 (1.9) n.d. 5 (0.5)
Downey4 1358 43 (3.2) 16 (1.2) 5 (0.4) 27 (2)
Inderbitzi and Grillet5 5280 93 (1.8) 23 (0.4) n.d. 16 (0.3)
Kaiser6 266 10 (3.8) 5 (1.9) 5 (1.9) n.d.
Hazelrigg et al.7 1820 43 (3.2) 21 (1.6) 21 (1.6) nil
Imperatori (2008) 1093 51 (4.7) 22 (2) 7 (0.6) 7 (0.6)
n.d.¼ not determined.
A. Imperatori et al. / International Journal of Surgery 6 (2008) S78–S81 S793. Prolonged air leak
Prolonged air leak is the most prevalent complication of VATS
and is more likely to occur after resection of lung nodules and
bullae.
After VATS lung biopsy, moderate air leakage from parenchyma
which has been sutured or biopsed or traumatized by instruments
occurs frequently. The thermal injury of electrocautery may also
predispose to prolonged air leak. As most patients can be dis-
charged within 48 h, persistent air leak should be avoided. Endo-
scopic stapling instruments of various sizes may be used to staple
and to resect leaking parenchyma. In the operating room, as the
lung is inﬂated, staple lines should be visualized for bleeding and
air leak. Even after complete control of air leakage, at the end of
each VATS procedure it is advisable to place routinely a chest tube,
under direct vision, to provide drainage of any subsequent air and
ﬂuid losses. As pointed out by Adebonojo the deﬁnition of
‘‘persistent air leak’’ is arbitrary.8 Indeed, postoperative air leak has
been reported with many different lengths of leakage (5–10 days),
which makes comparison of results difﬁcult.
In different large series prolonged air leak was reported,
respectively, in 3.2%,4 3.7%,9 4.7%,10 and 6.7%.3 In our experience air
leak longer than 7 days after 1093 VATS procedures occurred in 51
patients (4.7%).4. Bleeding
VATS usually offers an excellent visibility of the operative ﬁeld,
thus intrathoracic haemorrhage is rare. Bleeding occurs infre-
quently when an experienced surgeon performs the procedure; it is
more likely to occur in patients with dense adhesions. Bleeding
from one of the main pulmonary vessels during VATS, however, can
be very dangerous because haemorrhage is sudden and massive
and control is limited by the small access.10,11 Indeed VATS lung
resections of any type are contraindicated in patients with tumours
near the pulmonary hilum; VATS should be limited to biopsy for
diagnosis and a sponge stick should be available to apply pressure
immediately for controlling haemorrhage. With bleeding tempo-
rarily controlled, a decision is immediately made as to whether
thoracotomy is needed. Severe parenchymal haemorrhage may
require open thoracotomy and lobectomy for control. Haemorrhage
may also derive from trocar site access or from lung biopsy, but
these are uncommon events, that are more likely to occur if the
patient has a coagulation defect. Depending upon the circum-
stances, bleeding can be controlled by electro-coagulation, trans-
ﬁxed sutures, metal clips or with linear staplers. Kaiser and Bavaria
in 266 VATS reported postoperative bleeding (requiring trans-
fusion) in 1.9% of cases (four patients required thoracotomy).9
Walker et al. reported a postoperative bleeding rate of 0.5%.12 In our
series of 1093 VATS procedures bleeding occurred in 2% (22
patients required blood transfusion) (Table 1).5. Infectious complications
The literature data about infections complicating VATS proce-
dures are scarce, in spite of the increased application of VATS in
recent years. The few studies available refer to heterogeneous
patient populations undergoing various VATS procedures, that
cannot be easily compared.13 Thus the incidence of infections in the
VATS setting is not well deﬁned.
Rovera et al. reviewed 346 consecutive VATS procedures and
reported about the risk factors affecting the incidence of surgical
infection.14 Patients were divided into two groups: 139 patients
undergoing lung wedge resection and 207 patients undergoing
intrathoracic biopsy (pleura or mediastinal mass). The following
risk factors for infection were assessed: haemoglobin concentra-
tion, haematocrit, serum albumin concentration, blood lymphocyte
count, length of preoperative stay, duration of surgery, blood
transfusion, age, co-morbidity and speciﬁcally chronic obstructive
pulmonary disease (COPD, measured as FEV1<70% of expected).
Prophylactic antibiotics were given to more than 90% of patients in
both series. The endpoint measures were the occurrence of post-
operative infection within 30 days (surgical site infection, pneu-
monia, empyema) and the ﬁnal patient outcome. The authors found
that one or more postoperative infections occurred in 17/346
patients (4.9%, all of whom had received antibiotic prophylaxis). In
the VATS lung resection group the total infection rate was 6.5%, and
in the VATS biopsy group it was similar (6.3%). The incidence of
surgical site infection was similar in two groups (2.8% vs. 1.0%;
p¼NS) and the incidence of pneumonia was also similar (2.8% vs.
3.4%, p¼NS). All postoperative infections (surgical site, pneumonia,
empyema) were treated successfully with antibiotic or antifungal
therapy and surgical drainage as indicated. No postoperative deaths
occurred. The infection rate in the 50 VATS patients with COPD was
signiﬁcantly higher than in controls (14% vs. 4.9%; p< 0.01). COPD
was the only univariate predictor of postoperative infection. Indeed
FEV1<70% of predicted was observed much more frequently in
infected patients than in non-infected patients (58% vs. 25%;
p< 0.05).6. Postoperative pain
The surgical incisions of open thoracic operations are among the
most painful. They cause reduced lung function, impairment of
respiratory effort, atelectasis and ultimately hypoxemia. Moreover,
pain causes less patient mobilization and increases the incidence of
deep venous thrombosis and of pulmonary embolism. Several
traumatic factors are known to contribute to acute pain after
thoracic surgery: tissue trauma and drains, rib fracture and injury
to intercostal nerves (due to retractor or trocar). The prominent
causes of chronic postoperative pain are intercostal neuroma and
healing rib fracture. Essentially, in open thoracic surgery pain
results from the spreading of retractors.15
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after VATS procedures than after open thoracotomies. Walker
compared the requirement for narcotic pain drugs in 83 VATSmajor
pulmonary resection vs. 110 patients who underwent thoracotomy
during the same period and found that the VATS group required
signiﬁcantly less morphine (p< 0.001).10 In a randomised
prospective trial of lobectomy in 67 patients (47 by VATS and 23 by
muscle-sparing thoracotomy) Giudicelli et al. reported that post-
operative pain was signiﬁcantly less (p< 0.02) after VATS proce-
dures.16 Landreneau et al. prospectively evaluated daily narcotic
requirements, hospital stay and visual analogue pain scale in 165
patients after muscle-sparing thoracotomy compared with 178
patients after VATS.17 The latter patients had less pain and greater
shoulder strength in the ﬁrst 6 months postoperatively, but after 1
year the difference disappeared.17 The severity and duration of pain
after thoracotomy obviously depend on the degree of rib spreading
and on the site and modality of thoracotomy incision. Indeed,
Nomori et al. who compared VATS lobectomy vs. an anterior limited
thoracotomy approach, reported that patients in the VATS group
experienced much less pain in the ﬁrst postoperative week, but the
difference was not signiﬁcant subsequently.18
Landreneau et al. addressed the problem of chronic pain after
pulmonary resection by thoracotomy vs. VATS and found that
within the ﬁrst year after thoracotomy there was a signiﬁcantly
greater increase in the pain reported, as compared to VATS. After
1 year, however, they observed no statistically signiﬁcant differ-
ence in either reported pain level or shoulder dysfunction
(VATS 22%; thoracotomy 29%), or narcotic usage (VATS 6%;
thoracotomy 16%).17
7. Port site recurrence of tumour
Dissemination of thoracic tumours as a result of biopsy or
thoracotomy for resection with curative intent is rare. It has been
described that during VATS neoplastic cells can disseminate and
implant, causing tumour recurrence at the port site. This compli-
cation has been reported following VATS biopsy of lymph nodes
and after pulmonary wedge resection. Yim19 and Jancovici et al.3
noted an increased risk of local recurrence at the thoracoscopy port
sites when a retrieval device (glove or bag) was not used. They
further noted that recurrence occurredmore likely in operations for
selected tumour types, namely mesothelioma, metastatic sarcoma
and melanoma, or when malignant pleural effusion was present.
Mesothelioma is well known to invade thoracic incisions of all
types, including thoracotomy, needle biopsy tracks and chest drain
sites; similarly, malignant pleural effusions have been shown to
implant and cause recurrence in the thoracic wall at the drain sites.
In the surgical management of early stage tumours, however,
dissemination and chest wall implant of thoracic malignancy
resulting for manipulation is a phenomenon rarely observed.
After VATS lobectomy McKenna et al. in 1998 reported a very
low incidence of this complication: 1/298 patients of his series
(0.3%) developed chest wall recurrence in the utility thoracotomy
incision.20 Subsequently the same authors reviewed their further
experience with VATS lobectomy including 1100 cases and
conﬁrmed that the recurrence rate in the incision was very low
(0.57%).21 Also in the experience of the Memorial Sloan-Kettering
Cancer Center Thoracic Service the prevalence of port site tumour
recurrence was very rare: 1/374 patients (0.26%).22
8. Conversion to thoracotomy
In 321 patients undergoing VATS procedures for various indi-
cations Krasna et al. reported the need to convert to thoracotomy in
8% of cases.1 Most commonly the conversion to thoracotomy wasdeemed necessary because of oncological reasons, such as centrally
located tumours requiring vascular control or sleeve resection, or
unexpected T3–T4 tumours that inﬁltrate to the chest wall, dia-
phragm or superior vena cava. Abnormal hilar nodes with granu-
lomatous or metastatic disease adherent to the superior pulmonary
vein may be better evaluated and more safely resected with
thoracotomy. In the experience of Krasna et al. about 30% of
thoracotomy conversions were for non-oncological reasons, such as
pleural adhesions.1 In the series of the Memorial Sloan-Kettering
Cancer Center Thoracic Service conversion to open thoracotomy
because VATS was not technically adequate occurred in 44/410
patients (11%).19 In our experience of 1093 VATS procedures,
conversion to thoracotomy was done in 19 patients (1.7%), for one
of the following reasons: inability to localize precisely the lesion to
biopsy or resect; bleeding that was difﬁcult to control; and exten-
sive pleural adhesions.9. Conclusions
Video-assisted thoracic surgery (VATS) has been widely used in
the diagnosis and management of an heterogeneous population
affected by intrathoracic diseases with a low impact on intra-
operative and postoperative morbidity, indeed the analysis of the
data available in the literature shows that VATS is a reliable and safe
approach for the diagnosis and treatment of pulmonary diseases
with a low complication rate (less than 10%) and a mortality rate
less than 1–2%.23,24
In our experience and in the reviewed literature, the most
frequent complications after VATS procedures are: prolonged air
leak, bleeding, infection, postoperative pain, port site recurrence
and the need to convert the access into thoracotomy. Their rate of
occurrence is generally low and VATS procedures are considered
safe and effective, as witnessed by the fact that they constitute
about one-third of all thoracic surgical procedures.
However, to further reduce peri-operative complications, it
is necessary to preoperatively identify high-risk patients, to
improve modiﬁable clinical conditions with medical supports, and
to adopt a meticulous surgical technique (the most important
determinant).
It should be recommended that all thoracic surgical depart-
ments audit their peri-operative morbidity and mortality to
compare results and outcomes.Conﬂict of interest
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